Leo Wealth’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$271K Buy
+2,851
New +$304K 0.06% 218
2026
Q1
$269K Sell
3,088
-3,864
-56% -$376K 0.02% 383
2025
Q4
$744K Sell
6,952
-915
-12% -$97.1K 0.05% 209
2025
Q3
$794K Sell
7,867
-5,578
-41% -$518K 0.1% 143
2025
Q2
$850K Sell
13,445
-2,555
-16% -$156K 0.07% 182
2025
Q1
$848K Buy
+16,000
New +$888K 0.12% 139

Other funds holding RYTM

Leo Wealth's RYTM Position: Q3 2026 in Review

Leo Wealth opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 2,851 shares worth $271K. The stake represents 0.06% of the portfolio and ranks #218 among its holdings. This is a return to the name: Leo Wealth previously reported a position in RYTM as recently as Q1 2026.

Leo Wealth first reported a position in RYTM in Q1 2025 and has held it in 6 quarters since. The position peaked at $850K in Q2 2025. 239 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Leo Wealth held 2,851 shares of Rhythm Pharmaceuticals worth $271K as of Q3 2026.
  • Rhythm Pharmaceuticals was a new Leo Wealth position in Q3 2026.
  • Rhythm Pharmaceuticals made up 0.06% of Leo Wealth's portfolio in Q3 2026, its #218 holding.
  • Leo Wealth first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Leo Wealth's Rhythm Pharmaceuticals position peaked at $850K in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Leo Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.